Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 4.89% vs 31.44% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 21.32% vs 58.01% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -97.77% vs 273.96% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 20.11% vs 54.64% in Mar 2024
Compare Profit and Loss Results of Influx Health.
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
104.00
133.00
-29.00
-21.80%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
104.00
133.00
-29.00
-21.80%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
3.00
-3.00
-100.00%
Raw Materials Consumed
63.00
112.00
-49.00
-43.75%
Power & Fuel Cost
1.00
5.00
-4.00
-80.00%
Employee Cost
8.00
4.00
4.00
100.00%
Operating Expenses
7.00
3.00
4.00
133.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
1.00
0.00
0.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
5.00
-5.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
84.00
138.00
-54.00
-39.13%
Operating Profit (PBDIT) excl Other Income
20.00
-4.00
24.00
600.00%
Other Income
0.00
5.00
-5.00
-100.00%
Operating Profit (PBDIT)
20.00
0.00
20.00
0%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
20.00
0.00
20.00
0%
Depreciation
2.00
2.00
0.00
0.00%
Profit Before Taxation & Exceptional Items
17.00
-1.00
18.00
1,800.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
17.00
-1.00
18.00
1,800.00%
Provision for Tax
4.00
0.00
4.00
0%
Profit After Tax
13.00
-2.00
15.00
750.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
16.00
52.00
-36.00
-69.23%
Profit Available for appropriations
29.00
49.00
-20.00
-40.82%
Appropriations
29.00
49.00
-20.00
-40.82%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
7.36
-0.5
7.86
1,572.00%
Profit And Loss - Net Sales
Net Sales 104.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.89% vs 31.44% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.32% vs 58.01% in Mar 2024
Profit And Loss - Interest
Interest 0.01 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -97.77% vs 273.96% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 13.37 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.11% vs 54.64% in Mar 2024
Footer loading
